USPTO trademark

MATCEPER

Under examinationUSPTOFigurative markClass 42

"MATCEPER" is a figurative mark owned by Hangzhou Adlai Nortye Biopharma Co., Ltd., filed at the USPTO on July 2, 2026. It is under examination and covers class 42 (Computer and Scientific Services).

Official USPTO record
MATCEPER trademark as filed
As filed with the USPTO
Status
Under examination
Since July 2, 2026
Filed
July 2, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99918844
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns MATCEPER

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services MATCEPER is filed for, grouped by Nice class.

  • Scientific research; Scientific research for medical purposes in the area of cancerous diseases; Medical research services in the field of cancer; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research laboratories; Development of pharmaceutical preparations and medicines; Testing of pharmaceuticals; Pharmaceutical product evaluation; Computer programming in the medical field

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About MATCEPER

Who owns the trademark "MATCEPER"?

The USPTO trademark "MATCEPER" (application 99918844) is owned by Hangzhou Adlai Nortye Biopharma Co., Ltd.

What is the status of "MATCEPER"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MATCEPER and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019f281a-ae07-73f0-a0d2-5c86822d2de8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f281a-ae07-73f0-a0d2-5c86822d2de8",
  "object": "trademark",
  "mark_text": "MATCEPER",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99918844",
  "filing_date": "2026-07-02",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Hangzhou Adlai Nortye Biopharma Co., Ltd.",
      "entity_id": "ent_019ebafe-592e-74fc-94b9-7df55a5ed453"
    }
  ]
}